<SEC-DOCUMENT>9999999995-22-002502-index.html : 20220826
<SEC-HEADER>9999999995-22-002502.hdr.sgml : 20220826
<ACCEPTANCE-DATETIME>20220826001512
ACCESSION NUMBER:		9999999995-22-002502
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20220825
DATE AS OF CHANGE:		20220826
EFFECTIVENESS DATE:		20220825

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Talaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001827506
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266875
		FILM NUMBER:		221199359

	BUSINESS ADDRESS:	
		STREET 1:		570 PRESTON ST.
		STREET 2:		SUITE 400
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		502-398-9250

	MAIL ADDRESS:	
		STREET 1:		93 WORCESTER STREET
		CITY:			WELLESLEY
		STATE:			MA
		ZIP:			02481
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>